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Raptor/mTORC1 loss in adipocytes causes
progressive lipodystrophy and fatty liver disease
Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin*
ABSTRACT
Objective: Normal adipose tissue growth and function is critical to maintaining metabolic homeostasis and its excess (e.g. obesity) or absence
(e.g. lipodystrophy) is associated with severe metabolic disease. The goal of this study was to understand the mechanisms maintaining healthy
adipose tissue growth and function.
Methods: Adipose tissue senses and responds to systemic changes in growth factor and nutrient availability; in cells mTORC1 regulates
metabolism in response to growth factors and nutrients. Thus, mTORC1 is poised to be a critical intracellular regulator of adipocyte metabolism.
Here, we investigate the role of mTORC1 in mature adipocytes by generating and characterizing mice in which the Adiponectin-Cre driver is used
to delete ﬂoxed alleles of Raptor, which encodes an essential regulatory subunit of mTORC1.
Results: RaptorAdipoq-cre mice have normal white adipose tissue (WAT) mass for the ﬁrst few weeks of life, but soon thereafter develop lip-
odystrophy associated with hepatomegaly, hepatic steatosis, and insulin intolerance. RaptorAdipoq-cre mice are also resistant to becoming obese
when consuming a high fat diet (HFD). Resistance to obesity does not appear to be due to increased energy expenditure, but rather from failed
adipose tissue expansion resulting in severe hepatomegaly associated with hyperphagia and defective dietary lipid absorption. Deleting Raptor in
WAT also decreases C/EBPa expression and the expression of its downstream target adiponectin, providing one possible mechanism of mTORC1
function in WAT.
Conclusions: mTORC1 activity in mature adipocytes is essential for maintaining normal adipose tissue growth and its selective loss in mature
adipocytes leads to a progressive lipodystrophy disorder and systemic metabolic disease that shares many of the hallmarks of human congenital
generalized lipodystrophy.
 2016 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
White adipose tissue (WAT) functions both as the body’s major
energy storage site, and as a critical endocrine tissue, and interest
in understanding its biology has intensiﬁed with the obesity
epidemic. Obesity (deﬁned as a BMI > 30) results from energy
imbalance and can lead to ectopic lipid deposition in non-adipose
tissues (e.g. the liver), type 2 diabetes, cardiovascular disease,
and some cancers. Obesity now affects more than 1 in 3 adults in
the United States, and between 8% and 25% of adults in countries
of the European Union, making this a major international clinical
problem of this era [1e3]. Lack of adipose tissue or lipodystrophy
also associates with severe metabolic complications. For example,
patients suffering from congenital generalized lipodystrophy (or
Berardinelli-Seip Syndrome) also develop insulin resistance,
hypertriglyceridemia, and fatty liver disease, which can lead to
hepatomegaly and liver failure. Thus, normal adipose tissue growth
and function is critical to maintaining metabolic homeostasis and
understanding the mechanisms that promote healthy fat has broad
clinical implications.
The mechanistic target of rapamycin complex 1 (mTORC1) integrates
multiple upstream signals from nutrient availability to promote anabolic
metabolism. For example, mTORC1 detects intracellular amino acid
availability through multiple sensors that converge upon the Rag
GTPases to control mTORC1 subcellular localization, and circulating
glucose levels through the insulin-signaling pathway, which promotes
mTORC1 activity through the TSC/Rheb pathway [4e6]. Thus, mTORC1
is poised to be a critical regulator of adipocyte function. To test this, we
conditionally deleted the essential mTORC1 regulatory subunit Raptor in
mature adipocytes with Adiponectin-Cre, which is reported to have
greater efﬁciency and speciﬁcity for mature adipocytes than aP2-Cre
[7e11]. We ﬁnd that RaptorAdipoq-Cre mice have normal WAT mass for
the ﬁrst few weeks of life, but progressively develop a lipodystrophy
disorder resembling human congenital generalized lipodystrophy
including insulin intolerance and hepatic steatosis. These and several
additional characteristics of the RaptorAdipoq-Cre mice differ signiﬁcantly
from those of mice in which Raptor was deleted with aP2-Cre [12]. Our
results provide a new framework for understanding how mTORC1
signaling helps maintain healthy adipose tissue and could provide
insight into human lipodystrophy disorders.
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2. MATERIALS & METHODS
2.1. Mice
Raptor ﬂoxed mice are described in [13] and were backcrossed 10
generations to C57BL/6 and crossed to mice expressing the
Adiponectin-Cre driver or the Ucp1-Cre driver (generous gifts of Evan
Rosen). Floxed Cre-negative mice were used as controls. Mice were
kept on a daily 12 h light/dark cycle and fed a normal chow diet
(Prolab Isopro RMH 3000) from Lab Diet ad libitum at 22 C. All
animal experiments were approved by the University of Massachusetts
Medical school animal care and use committee.
2.2. Antibodies and reagents
PPARg antibody is from Santa Cruz (sc-7196). UCP1 antibody is from
AbCam (ab-10983). All other antibodies were purchased from Cell
Signaling Technologies: ACC (3676), ACLY (4332), AKT (9727), P-AKT-
S473 (4058), ATGL (2439), FASN (3180), HSL (4107), P-HSL-S660
(4126), ULK1 (8054), P-ULK1-S757 (6888), 4EBP1 (9644), P-4EBP1-
S65 (9456), P-4EBP1-T37/46. All other reagents were from Sigmae
Aldrich.
2.3. Diet & metabolic studies
At 12 weeks of age, male mice were placed on a 60% high fat diet
(HFD) (D12492 Harlan Laboratories) for 8 weeks. Body weight was
recorded weekly. The analysis of blood metabolites was performed by
the Joslin Diabetes Center and MMPC at the University of Cincinnati.
For glucose tolerance tests (GTT) mice were fasted overnight (16 h)
and then administered 2 g/kg of body weight of glucose or sodium
pyruvate by intraperitoneal (i.p.) injection. For insulin tolerance tests
(ITT), mice were fasted for 6 h before i.p. administration of 0.75 unit/kg
of body weight of insulin. Blood glucose concentrations were
measured before and after the injection at indicated time points.
2.4. Tissue harvest and histology
Adipose tissue depots were carefully dissected to avoid contamination
from surrounding tissue. Samples for RNA or protein were snap frozen
in liquid nitrogen and stored at 80 C until analysis. For histology,
tissue pieces were ﬁxed in 10% formalin. Embedding, sectioning, and
Hematoxylin & Eosin (HE) staining was done by the UMass Medical
School Morphology Core. For Oil Red O staining, liver samples were
embedded in OCT before sectioning and staining. For cell size mea-
surements a minimum of 9e12 images were taken used per mouse
(n ¼ 3 wild type and 3 conditional knockouts). Image J was used to
measure cell size and the distribution of cell size as percentage of total
counted cells was analyzed.
2.5. Western blots
Tissue samples or cells were lysed in a buffer containing 50 mM
Hepes, pH 7.4, 40 mM NaCl, 2 mM EDTA, 1.5 mM NaVO4, 50 mM NaF,
10 mM sodium pyrophosphate, 10 mM sodium b-glycerophosphate
and 1% Triton X-100. Tissues were homogenized using a TissueLyser
(Qiagen) in the same lysis buffer supplemented with 0.1% SDS, 1%
sodium deoxycholate. Equal amounts of total protein were loaded into
acrylamide/bis-acrylamide gels and transferred to PVDF membranes
for detection with the indicated antibodies. Membranes were incubated
with primary antibodies in 5% milk/PBST or 5% BSA/PBST overnight.
Membranes were then incubated for 1hr with HRP-conjugated sec-
ondary antibodies. Western blots were developed by enhanced
chemiluminescence (PerkinElmer) and detected by X-ray ﬁlms. To
obtain UCP1 signaling from WAT lysates, ﬁlms were exposed for
varying durations, up to 12 hrs for the indicated “long exposure (LE)”.
2.6. Lipolysis
Excised pgWAT tissue was incubated in 12 well cell culture dishes in
DMEM with or without isoproterenol at 10 mM for 4 h, respectively,
before collecting medium to measure glycerol concentration using a
commercial kit (Sigma). The glycerol level was normalized with mass
of the excised tissue.
2.7. Fecal lipids extraction
Mice were housed individually for 48 h and 1 g of dried feces was
collected from each mouse. Feces were powderized using a tissue
grinder, and rehydrated in 5 ml of normal saline. A 2:1 chlor-
oform:methanol solution was used to extract lipids from the
suspension.
2.8. Body composition and metabolic cages
Mice were placed into metabolic cages for 3 days at 25 days into their
HFD feeding. Lean mass and whole body fat mass were measured
noninvasively using 1H-MRS (Echo Medical Systems, Houston TX), and
a 3-day measurement of physical activity, energy expenditure, respi-
ratory exchange ratio, and food intake were conducted using metabolic
cages (TSE Systems, Bad Homburg, Germany) by the UMass Mouse
Metabolic Phenotyping Center. Thereafter, mice were kept on HFD in
normal housing until dissection.
2.9. Gene expression analysis
Cells or tissues were lysed with Qiazol (Invitrogen) and total RNA
was isolated with the RNeasy kit (Invitrogen). Equal amounts of RNA
were retro-transcribed to cDNA using a High capacity cDNA reverse
transcription kit (#4368813, Applied Biosystems). Quantitative RT-
PCR was performed in 10 mL reactions using a StepOnePlus real-
time PCR machine from Applied Biosystems using SYBR Green
PCR master mix (#4309156, Applied Biosystems) according to
manufacturer instructions. Relative mRNA expression was deter-
mined by the DCt method, and Tbp (TATA sequence binding protein)
expression was used as a normalization gene in all conventional RT-
PCR experiments.
2.10. Statistics
Unless otherwise stated, values given are mean  SEM. Two-way
ANOVA was performed where indicated. For most experiments, un-
paired two-tailed Student’s t test was used to determine statistical
signiﬁcance among two groups (*p< 0.05; **p< 0.01; ***p< 0.001).
3. RESULTS AND DISCUSSION
3.1. Adipocyte Raptor KO mice have normal WAT mass early in life
To investigate the role of mTORC1 in adipocytes, we generated Adi-
ponectin-Cre;Raptorﬂ/ﬂ mice (herein RaptorAdipoq-cre mice). Raptor-
Adipoq-cre mice are born at the expected Mendelian ratio and are grossly
indistinguishable from their littermates at birth. At post-natal day 14
(P14), there is no difference in total body weight between control and
RaptorAdipoq-cre mice (Figure 1A). The major subcutaneous and visceral
perigonadal white adipose tissue depots (sWAT and pgWAT) are not
signiﬁcantly different in mass from controls at P14 (Figure 1B). Liver
mass at P14 is also not signiﬁcantly different though it is trending
slightly larger in the KOs; the mass of other lean tissues such as the
heart, kidney, and skeletal muscle is normal (Figure 1C). We conﬁrmed
Raptor loss by Western blots using whole sWAT and interscapular
brown adipose tissue (iBAT) depots (Figure 1D); the residual signal
reﬂects the non-adipocyte population (see Section 3.2). Inactivation of
mTORC1 activity was conﬁrmed by decreased phosphorylation of the
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mTORC1 substrates 4E-BP1 (on phospho-T37/46) and ULK1 (on
phospho-S757), and by increased phosphorylation of AKT (on
phospho-S473), which is caused by loss of the well-known mTORC1-
mediated feedback inhibition of insulin/AKT signaling (Figure 1D) [4].
We also noted a slight decrease in total ULK1 protein in the KO tissues
(Figure 1D).
In post-natal development, the sWAT adipocytes exhibit characteristics
of brown adipocytes including the presence of multi-locular lipid
droplets and positive UCP1 expression (Figure 1D,E) [14,15]. These
adipocytes are called brite or beige adipocytes to distinguish them
from classic brown adipocytes [16], and with age, they usually convert
to or are replaced by more classic-looking unilocular white adipocytes.
RaptorAdipoq-cre mice exhibit no defect in the post-natal formation of
brite/beige adipocytes in the sWAT as determined by UCP1 protein
expression (Figure 1D) and the appearance of multilocular adipocytes
(Figure 1E). There is also no difference in the histological appearance
of the pgWAT adipocytes or the liver at P14 (Figure 1E). Thus, Raptor is
dispensable in white adipocytes for post-natal adipose tissue growth
and normal adipocyte size, and for post-natal formation of brite/beige
adipocytes in the sWAT.
In contrast, the interscapular and subscapular brown adipose
tissue depots (iBAT and sBAT) of RaptorAdipoq-cre mice are
Figure 1: Adipocyte Raptor KO mice exhibit normal WAT mass and mild BAT defects early in life. (A) Body weight measurements of KO (n ¼ 6) and wt (n ¼ 6) mice at 14
days of age. (B) Fat tissue mass of KO and wt mice at 14 days of age. (C) Lean tissue mass of KO and wt mice at 14 days of age. (D) Western blots of whole tissue lysate from iBAT
and sWAT depots for indicated proteins. (E,F) Representative H&E images of tissues at indicated magniﬁcation. (Data were analyzed by Student’s t-test. Values expressed as
mean þ SEM. *p < 0.05; **p < 0.01; ***p < 0.001).
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reduced in mass by 37% and 48% respectively at P14
(Figure 1B). We also noted an increase in the number of brown
adipocytes containing large lipid droplets in the Raptor KO BAT
(Figure 1F). To test whether this phenotype is tissue autonomous,
we deleted Raptor with Ucp1-Cre. This also results in a signiﬁ-
cant size reduction of the BAT depots (Figure S1A) and the
heterogeneous appearance of larger lipid droplets (Figure S1B).
Total body mass and individual WAT depot mass was normal in
RaptorUcp1-Cre mice (Figure S1CeD). Thus, while adipocyte Raptor
is dispensable for post-natal WAT growth, it is required autono-
mously in brown adipocytes for normal post-natal BAT growth
and lipid droplet size.
Figure 2: Adipocyte Raptor KO mice develop lipodystrophy with age. (A) Body weight growth chart of wt (n ¼ 6) and KO (n ¼ 6) mice up to 12 weeks. Food intake of adult KO
and wt mice. (B) Fat tissue mass of KO and wt mice atw12 weeks of age. (C) Representative images of adult KO and wt mice, and indicated WAT and BAT depots. (D) Western
blots from whole tissue lysate for indicated proteins. (E) Western blots from isolated mature adipocytes for indicated proteins. (F) Representative H&E images of WAT depots from
KO and wt mice. (G) Distribution of adipocyte diameter (microns) in pgWAT depots from w12 week old mice on chow diet.
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3.2. Adipocyte Raptor KO mice progressively develop lipodystrophy
associated with hepatic steatosis and insulin intolerance
During the ﬁrst 4 months of life, RaptorAdipoq-cre mice consuming a
normal chow diet (NCD) tend to be slightly heavier than controls
although this does not reach statistical signiﬁcance at least by 12 weeks
of age (p value¼ 0.066) (Figure 2A, left). RaptorAdipoq-cre mice also tend
to eat slightly more food but again this was not statistically signiﬁcant (p
value¼ 0.25) (Figure 2A, right). However, despite their relatively normal
body weight, RaptorAdipoq-cre mice fail to expand their white adipose
tissueswith age. For example, the KO sWAT, retroperitoneal WAT (rWAT)
and pgWAT are 35%, 37%, and 54% smaller respectively in the KOs
compared to age matched controls (Figure 2B,C); KO BAT tissues also
remained small (Figure 2B,C). Thus, adipocyte Raptor KO mice pro-
gressively develop lipodystrophy with age.
We also conﬁrmed Raptor loss and mTORC1 inactivation in whole
sWAT and pgWAT depots from the 12-week old mice (Figure 2D). The
residual Raptor signal is from stromal vascular fraction (SVF) cells as
Raptor is virtually undetectable in puriﬁed mature adipocytes
(Figure 2E). Histological analysis of the white adipocytes from 12-week
old RaptorAdipoq-cre mice revealed a heterogeneous size distribution
pattern (Figure 2F). For example, pgWAT adipocytes in the RaptorAdipoq-
cre mice show a bimodal distribution in which the relative number of
small (<100 mM) and large (>200 mM) adipocytes is signiﬁcantly
increased compared to controls (Figure 2G). The mutant sWAT also
contains two populations of adipocytes: a pool of large unilocular
adipocytes and a pool of smaller adipocytes containing multiple lipid
droplets (Figure 2F). Thus, with age the RaptorAdipoq-cre mice also
cannot maintain normal adipocyte morphology.
Strikingly, at 12-weeks of age there is also a 46% increase in liver
mass in the RaptorAdipoq-cre mice compared to controls that is asso-
ciated with a paler color suggesting hepatic steatosis (Figure 3A,B).
The overgrowth of non-adipose tissues is largely restricted to the liver
as the mass of other lean tissues including the heart and skeletal
muscles is unchanged (Figure 3A). We conﬁrmed hepatic steatosis by
Oil Red O staining, which revealed a marked increase in lipid staining
in the KO (Figure 3C). Consistently, expression of the major de novo
lipogenesis (DNL) enzymes ATP-citrate lyase (ACLY), Acetyl-CoA
Carboxylase (ACC) and Fatty Acid Synthase (FASN) are also
increased in RaptorAdipoq-cre KO livers (Figure 3D). RaptorAdipoq-cre KO
mice are also insulin intolerant exhibiting a 54% increase in AUC in
insulin tolerance tests (Figure 3E, top); glucose tolerance is normal
(Figure 3E, bottom). Serum chemistry analysis indicates normal
circulating free fatty acids (FFAs) (p¼ 0.77), but a trending increase in
circulating triacylglycerides (TAGs) (p ¼ 0.0851) and cholesterol
Figure 3: The progressive lipodystrophy of adipocyte Raptor KO mice associates with hepatic steatosis and insulin intolerance. (A) Lean tissue mass of KO and wt mice
atw12 weeks of age. (B) Representative images of liver from KO and wt mice atw12 weeks. (C) Representative H&E images of liver from KO and wt mice. (D) Western blots of
liver lysate for indicated proteins. (E) ITT and GTT of adult KO and wt mice. (F) Serum chemistry levels of FFA, TG, and Cholesterol for adult wt and KO mice on chow diet. (G) Serum
insulin levels for adult wt and KO mice. (H) Serum adiponectin levels for adult wt and KO mice. (Data were analyzed by Student’s t-test. Values expressed as mean þ SEM.
*p < 0.05; **p < 0.01; ***p < 0.001).
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(p ¼ 0.067) (Figure 3F). Insulin levels are not signiﬁcantly different
(Figure 3G). We conclude that the progressive lipodystrophy in Rap-
torAdipoq-cre mice is causing systemic metabolic disease including in-
sulin intolerance, hyperlipidemia, and non-alcoholic fatty liver disease
(NAFLD).
3.3. Altered lipid metabolic pathways in adipocyte Raptor KO mice
The mTORC1 inhibitor rapamycin can stimulate lipolysis in cultured
adipocytes [17,18]. Therefore, we examined the major regulators of
lipolysis in Raptor-deﬁcient adipose tissues. We did not observe a
signiﬁcant increase in hormone sensitive lipase (HSL) phosphorylation
between control and KO in pgWAT at 12 weeks of age; in fact it was
slightly lower (Figure 2D). We also did not detect increased adipose
triglyceride lipase (ATGL) protein levels in the sWAT of RaptorAdipoq-cre
mice; however, we could detect a slight increase in ATGL in the pgWAT
(Figure 2D) that correlated with a modest increase in basal glycerol
release from tissue explants (Figure 4A). However, Atgl mRNA was
decreased in both WAT depots (Figure 4B). Additionally, we examined
regulators of lipogenesis. In the pgWAT of RaptorAdipoq-cre mice we
detected signiﬁcant increases in Acly (2.5 fold), Acc (2.1 fold), and
Fasn (2.1 fold) mRNA (Figure 4C left) and protein (Figure 2D). Similar
increases occur in the sWAT although only the increase in Acly mRNA
reaches signiﬁcance even though ACLY, ACC and FASN proteins are all
elevated in this depot (Figures 2D, 4C right). Consistently, expression of
Chrebpb, which encodes an isoform of ChREBP that potently induces
transcription of the DNL genes [19], increases by 124-fold and 48-fold
in pgWAT and sWAT respectively (Figure 4D). This is interesting
because although DNL contributes only a fraction to the total lipid pool
of adipocytes, increased Chrebpb expression and DNL often correlate
with insulin sensitivity [19] indicating this can be uncoupled in the
RaptorAdipoq-cre mice. Moreover, while the mTORC1 substrate ULK1 is
well known to control autophagy, in mature adipocytes it may have an
additional role in lipogenesis downstream of mTORC1 as in vitro
knockdown of Ulk1 in differentiated 3T3L1 adipocytes increases Acc
and Fasn expression [20]. Thus, in vivo Raptor loss in mature adipo-
cytes alters the normal regulation of lipid metabolic pathways, possibly
with depot-dependent variances.
3.4. Raptor KO mice are resistant to diet-induced obesity but
develop severe hepatic steatosis
We next asked whether RaptorAdipoq-Cre mice could increase their fat
mass if placed on an obesogenic high fat diet (HFD). Beginning at 12-
weeks of age, RaptorAdipoq-Cre mice and their age matched controls
were switched onto a HFD for 8-weeks. Controls gained on average
9.4 g of body weight while in contrast RaptorAdipoq-Cre mice gained only
2.5 g resulting in a 14% difference in total body mass between the two
cohorts after 8 weeks (Figure 5A). Body composition analysis indicates
the weight difference is due to a 5-fold decrease in fat mass in the
mutants, which notably also have slightly higher lean mass (Figure 5B).
The difference in fat mass is clearly evident upon dissection (Figure 5C)
and individual tissue mass measurements (Figure 5D). Comparing the
average mass of individual WAT depots at the start and end of HFD
feeding shows that control sWAT increases by 5.9 fold and pgWAT by
6.5 fold while the mutant sWAT and pgWAT barely grow, increasing by
only 1.9 fold and 1.3 fold, respectively (Figure 5E). Interestingly,
comparing individual adipocyte size at the start and end of HFD feeding
indicates that the control and KO adipocytes in both depots increase in
size although the size heterogeneity in the KO tissue is still apparent
(Figure 5F). Thus, despite the inability of whole Raptor KO depots to
expand on HFD, Raptor KO adipocytes appear to retain some ability to
grow by hypertrophy.
Importantly, at the conclusion of HFD-feeding, the livers of the KO mice
are noww80% larger than controls (as opposed to 46% larger at the
start of feeding) resulting in a liver/body weight ratio that is now nearly
twice of that of controls (Figure 5G,H,I). The livers of the KO mice also
exhibit signiﬁcantly more severe hepatic steatosis (Figure 5J). Muscle
and heart mass remain unchanged between the cohorts (Figure 5G).
Thus, the inability of adipose tissues to expand in HFD-fed RaptorAdipoq-
Cre mice results in more redistribution of lipids to the liver.
3.5. Adipocyte Raptor KO mice have normal energy expenditure
and a lipid absorption defect
Next we explored possible mechanisms by which deleting Raptor in
adipocytes restricts adipose tissue growth. One possibility is that
Raptor increases energy expenditure (EE), which protects against
obesity. We reasoned that the severe hepatic steatosis and hepato-
megaly observed in both chow and HFD fed RaptorAdipo-Cre cohorts
argues against this scenario. However, the concept was previously
proposed in a study that used aP2-Cre to delete Raptor in adipose
tissue [12]. This study observed normal food intake but resistance to
HFD and improved insulin tolerance in RaptoraP2-Cre mice and this was
attributed to increased in Ucp1 mRNA expression in pgWAT and
elevated EE; hepatic steatosis and hepatomegaly was not observed in
RaptoraP2-Cre mice. Indeed, we ﬁnd that Ucp1 mRNA is increased in
both the sWAT and pgWAT of RaptorAdipo-Cre mice consuming chow
diet (Figure 6A). This correlates with elevated Pgc1a levels in sWAT,
and elevated Cpt1 in both sWAT and pgWAT (Figure 6A). However, in
chow fed mice UCP1 protein was barely detectable in either WAT depot
(Figure 6B). Moreover, we could only detect a slight increase in UCP1
protein in the sWAT of HFD-fed RaptorAdipo-Cre mice after a long
exposure (Figure 6B). This suggests that total UCP1 protein is only
slightly elevated in the sWAT of RaptorAdipo-Cre mice.
To better assess energy balance we also performed metabolic cage
experiments. We found no difference in EE between HFD-fed Raptor-
Adipoq-cre mice and controls when expressing the data “per mouse” as
recommend in [16] (Figure 6C). However, because it is often debated
which method of reporting is correct, we provide the raw data in
Table S1. We also found that the Respiratory Exchange Ratio (RER) is
higher in RaptorAdipoq-cre mice indicating greater utilization of carbo-
hydrates for fuel (Figure 6D). RaptorAdipoq-cre mice also exhibited
normal physical activity (Figure 6E) yet interestingly, they are hyper-
phagic consuming nearly twice as much food as controls (Figure 6F).
Hyperphagia is likely explained by the fact that HFD-fed RaptorAdipoq-cre
mice have greatly reduced circulating leptin (Figure 6G). We also
examined fecal lipids and found nearly twice the amount of lipid in the
feces of RaptorAdipoq-cre mice (Figure 6H) indicating a lipid absorption
defect. Thus, the mechanism causing resistance to obesity in Rap-
torAdipoq-cre mice cannot be explained by decreased food intake or
increased EE.
Based on the increased EE reported in aP2-Cre;Raptor mice, it was
suggested that adipose mTORC1 could be a potential target for anti-
obesity drugs. However, our results indicate several important
phenotypic differences compared to RaptoraP2-Cre mice (see detailed
comparison in Table S2). These differences likely reﬂect recent data
indicating that the aP2-Cre driver has limited efﬁciency for adipocytes
and targets non-adipocytes such as endothelial cells [7e11]. It would
be interesting to identify the exact target cell/mechanism responsible
for the beneﬁcial metabolic effects of deleting Raptor with aP2-Cre.
Nevertheless, in light of our characterization of RaptorAdipoq-Cre mice,
we would argue against prolonged targeting of mTORC1 in fat as a
strategy to reduce obesity, though the effects of temporal or partial
mTORC1 loss have not been thoroughly explored.
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3.6. Decreased C/EBPa activity in Raptor-deﬁcient WAT
We next asked whether adipocytes require mTORC1 to maintain
expression of Pparg, which encodes the master transcriptional regu-
lator of adipocyte differentiation and function, and is a marker of
adipocyte identity. We saw no signiﬁcant changes in Pparg mRNA
expression in the sWAT or pgWAT from RaptorAdipoq-Cre mice eating
chow or HFD (Figure 6I) suggesting Raptor is not required to maintain
adipocyte identity per se. We also examined the expression of CD36
and Lpl, two Pparg targets. In chow fed mice, Lpl tended to be lower
while CD36 unaffected (Figure 6J); in the HFD group, both genes are
reduced (Figure 6J). Thus, Pparg activity, particularly during high fat
feeding, may be altered in Raptor KO adipocytes.
Figure 4: Altered lipid metabolic pathways in the adipose tissues of adipocyte Raptor KO mice. (A) Concentration of glycerol from media of incubated excised pgWAT depots
under speciﬁed conditions. (B) ATGL mRNA from whole tissue lysate. (C) Acly, Acc, and FasN mRNA expression in pgWAT and sWAT. (D) Chrebpb mRNA expression in pgWAT and
sWAT.
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In contrast to Pparg, expression of the Pparg co-regulator C/EBPa (the
founding member of the CCAAT/enhancer-binding family) is greatly
reduced in the sWAT of both chow and HFD-fed mice as well as in
pgWAT, though to a lesser extent in this depot (Figure 6K). Interest-
ingly, it was recently reported that C/EBPa in mature adipocytes is
dispensable for terminal embryonic adipogenesis and adult adipocyte
survival, but required for normal adipose tissue expansion during high
fat diet feeding [21]. C/EBPa also promotes adiponectin expression
[22e24]. Indeed, adiponectin mRNA expression in WAT (Figure 6L)
and circulating Adiponectin levels (Figure 3H) are greatly reduced in
RaptorAdipoq-Cre mice. Thus, decreased C/EBPa activity provides a
possible mechanism to explain why only older RaptorAdipoq-Cre mice are
resistant to adipose tissue expansion.
3.7. Comparison to human lipodystrophy
RaptorAdipoq-Cre mice bear phenotypic resemblance to human patients
suffering from congenital generalized lipodystrophy or Berardinelli-
Seip lipodystrophy [25]. These patients suffer from adipose tissue
loss, and similar to the RaptorAdipoq-Cre model, exhibit insulin resis-
tance, hepatic steatosis, hypertriglyceridemia, and increased RER.
Nearly a quarter of the patients develop diabetes mellitus. Other clinical
features can include ectopic lipid in muscle and hypertrophic
cardiomyopathy. Berardinelli-Seip lipodystrophy is linked to mutations
in AGPAT2 or BSCL2/seipin but the molecular basis of the disease is
poorly understood. Interestingly, AGPAT2 and BSCL2 knockout models
exhibit several phenotypic similarities to RaptorAdipoq-Cre mice [26e28].
Moreover, the mTORC1 substrate Lipin-1, a phosphatidic acid phos-
phatase mutated in fatty liver dystrophy (ﬂd) mice, was recently shown
to physically interact with Seipin and AGPAT2 [29e31]. Thus, Rap-
torAdipoq-Cre mice may be useful in understanding the mechanistic basis
of human congenital lipodystrophy.
4. CONCLUSIONS
In this study we investigated the in vivo role of mTORC1 in mature
adipocytes by deleting Raptor with Adiponectin-Cre. We conclude
that mTORC1 activity in white adipocytes is dispensable for early
post-natal WAT growth, but becomes essential for normal adipose
tissue expansion with age. Moreover, adipocyte Raptor KO mice
consuming a high fat diet are hyperphagic yet resistant to obesity.
However, despite increased Ucp1 mRNA expression in WAT, these
mice are not protected from obesity due to increased energy
expenditure. Rather, they appear to have a defect in adipose tissue
expansion, which redistributes lipids to the liver resulting in severe
Figure 5: Adipocyte Raptor KO mice are resistant to HFD obesity but suffer from more severe hepatic steatosis. (A) Body weight, and weight gain of mice over course of
HFD. (B) Body weight and body composition afterw4 weeks HFD. (C) Representative images of inguinal fat depots after HFD. (D) Adipose depot masses at the end of HFD course.
(E) Fold increase in WAT depot mass after HFD feeding. (F) Representative H&E images of speciﬁed tissues before and after HFD. (G) Lean tissue mass after HFD. (H) Representative
images of liver after HFD. (I) Liver/BW ratio of mice after HFD. (J) Representative ORO staining of liver samples after HFD. (Data were analyzed by Student’s t-test. Values expressed
as mean þ SEM. *p < 0.05; **p < 0.01; ***p < 0.001).
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hepatomegaly and hepatic steatosis, and causes a dietary lipid ab-
sorption defect. It does not appear that mTORC1 activity is required
in WAT to maintain Pparg expression, but it may promote PPARg
activity towards certain targets. We also ﬁnd that mTORC1 is
required for normal C/ebpa and adiponectin expression providing a
plausible link to the adipose tissue expansion defect in older mice.
We found no obvious indication that adipocytes were dying in large
numbers (i.e. crown-like structures) at least at the time-points
examined. One hypothesis is that increased autophagy coupled
with defective lipid metabolic pathways, perhaps in part through
altered ULK1 and/or Lipin function, could cause defective triglyceride
accumulation and/or adipose tissue wasting. Alternatively, mTORC1
Figure 6: Energy utilization and adipocyte transcriptional regulation. (A) mRNA expression levels from whole tissue lysate from Chow fed mice for indicated genes. (B)
Western blots of whole tissue lysate for indicated proteins from both chow and HFD mice, along with exposure times. SE is short exposure, LE is long exposure. (C) Mean energy
expenditure per mouse over 24 hrs, with AUC. (D) Mean respiratory exchange ratio per mouse over 3 days, with AUC. (E) Mean activity per mouse over 3 days, with AUC. (F) Daily
food intake per mouse after 4 weeks on HFD. (G) Serum leptin concentration after HFD. (H) Fecal lipid content after 4 weeks HFD. (I) PPARy mRNA expression levels in whole tissue
lysate for respective mouse models. (J) mRNA expression levels of PPARy targets in whole tissue lysate for respective mouse models. (K) C/EBPa mRNA expression levels from
whole tissue lysate for respective mouse models. (L) Adiponectin mRNA expression from whole tissue lysate for respective mouse models. (Data were analyzed by Student’s t-test.
Values expressed as mean þ SEM. *p < 0.05; **p < 0.01; ***p < 0.001).
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in mature adipocytes may promote WAT expansion in older mice by
regulating production of a pro-adipogenic paracrine signal. Inter-
estingly, mTORC1 may have a unique function in neo-natal BAT
development that requires further examination. Because mTORC1
has several known and putative substrates [32,33] it will be
important to continue delineating the expression and contributions of
each downstream pathway in WAT maintenance in vivo using the
most updated and precise genetic and metabolic strategies.
We also found that mTORC1 loss did not impair the post-natal BAT-like
character of sWAT. Interestingly, it was recently reported that rapa-
mycin blocks the “browning” of WAT in adult mice by inhibiting
mTORC1 in mature adipocytes [34,35] suggesting there may be dif-
ferential requirements for mTORC1 in post-natal versus adult brite/
beige adipocyte formation. Moreover, another study reported that
increased mTORC1 signaling in BAT promotes a brown-to-white
phenotypic switch, and in this model, rapamycin reversed the “whit-
ening” of BAT [36]. Thus, the precise role of mTORC1 in BAT/WAT
interconversions remains to be seen.
Notably, our conclusions are based on chronic (congenital) Raptor loss
in adipocytes and thus the primary in vivo defect associated with losing
mTORC1 activity cannot be determined by this approach. Moreover, it
is clearly difﬁcult to obtain the perfect Cre-driver for tissue-speciﬁc KO
studies, thus future advances may lead to additional reﬁnements in
understanding mTORC1 signaling in fat. Nevertheless, RaptorAdipoq-Cre
mice exhibit phenotypic similarities to human patients suffering from
congenital generalized lipodystrophy suggesting this model may have
signiﬁcant clinical implications.
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